SpartaLabs
June 17, 2026
Tesamorelin: Sourcing, Purity, and Verification Standards
How SpartaLabs sources, tests, and verifies tesamorelin for research applications. Educational reference.
tesamorelinsourcingquality
Research library
Peptide research library
Published literature, mechanisms, and protocols — organized by compound. Educational reference, not medical advice.
All articles
SpartaLabs
June 17, 2026
Tesamorelin: Published Research
A bibliographic summary of published clinical and pharmacological research on tesamorelin — pivotal trials, GH-axis pharmacodynamics, hepatic outcomes, and active research frontiers. Educational reference.
tesamorelinclinical-trialsghrh-analog
SpartaLabs
June 17, 2026
Tesamorelin: A Research Overview
A research-library overview of tesamorelin — chemistry, GHRH-analog pharmacology, FDA approval history, and discovery lineage of this synthetic peptide. Educational reference.
tesamorelinghrh-analoggrowth-hormone-axis
SpartaLabs
June 17, 2026
Tesamorelin Mechanism of Action
A research-focused examination of tesamorelin's reported mechanism — GHRH receptor binding, GH-axis signaling cascade, and pharmacological basis for its activity as a GHRH analog. Educational reference.
tesamorelinghrh-receptorgh-axis
SpartaLabs
June 17, 2026
Tesamorelin: Discovery and Regulatory History
A chronological account of tesamorelin's development — from the isolation of endogenous GHRH in 1982 through Theratechnologies' clinical program, FDA approval of Egrifta in 2010, and continued research through 2025. Educational reference.
tesamorelinghrh-analogregulatory-history